Increase in trimethoprim-sulphamethoxazole (co-trimoxazole) resistance at Chris Hani Baragwanath Hospital, Soweto, in the AIDS era [7]

South African Medical Journal

Volumn 94, Issue 6 I, 2004, Pages 440-442

  Crewe Brown, Heather H ^a   Reyneke, Maria P ^a   Khoosal, Manikant ^a   Becker, Piet J ^b   Karstaedt, Alan S ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL INFECTION; BACTERIUM ISOLATE; CEREBROSPINAL FLUID; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA MULTIFORME; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LETTER; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; SALMONELLOSIS; SOUTH AFRICA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEVENS JOHNSON SYNDROME; TOXOPLASMOSIS; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; HIV INFECTIONS; HUMANS; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; RISK FACTORS; SOUTH AFRICA; TOXOPLASMOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UNITED STATES;

EID: 3042733914     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. The Joint United Nations Programme on HIV/AIDS. Provincial WHO/UNAIDS Secretariat Recommendations on the Use of Co-trimoxazole Prophylaxis in Adults and Children with HIV/AIDS in Africa. Geneva: UNAIDS, 2000.
2. Wiktor SZ, Sassan-Morokro M, Grant AD, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomized controlled trial. Lancet 1999; 353: 1469-1475.
3. Anglaret X, Chêne G, Attia A, et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Lancet 1999; 353: 1463-1468.
4. Department of Health. Prevention and Treatment of Opportunistic and HIV-related Diseases in Adults. Pretoria: HIV/AIDS and STD Directorate, Department of Health, 2000.
5. Department of Health. Managing HIV Infection in Children, Pretoria: HIV/AIDS and STD Directorate, Department of Health, 2000.
6. Badri M, Ehrlick R, Wood R, Maartens G. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: An evaluation of the provisional WHO/UNAIDS recommendations. AIDS 2001;15:1143-1148.
7. Maynart M, Lievre L, Sow PS, et al. Primary prevention with co-trimoxazole for HIV-1 infected adults: Results of the pilot study in Dakar, Senegal. J Acquir Immune Defic Syndr 2001; 26: 130-6.6.
8. Dworkin MS, Williamson J, Jones JL, et al. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: Impact on risk for infectious disease. Clin Infect Dis 2001; 33: 393-398.
9. Wininger DA, Fass RJ. Impact of trimethoprim-sulfamethoxazole prophylaxis on etiology and susceptibilities of pathogens causing human immunodeficiency virus - associated bacteremia. Antimicrob Agents Chemother 2002; 46: 595-597.
10. Martin JN, Rose DA, Hadley WK, Perdeau-Remington F, Lam PK, Gerberding JL. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. J Infect Dis 1999; 180: 1809-1818.
11. Rieder MJ, King SM, Read S. Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection. Pediatr Infect Dis J 1997; 16: 1028-1031.
12. Karstaedt A, Grannum S. Pneumocystis carinii pneumonia in patients with AIDS in South Africa. Trans R Soc Trop Med Hyg 2001; 95: 40-41.